Preferred Label : vasotocin;
MeSH definition : A nonapeptide that contains the ring of OXYTOCIN and the side chain of ARG-VASOPRESSIN
with the latter determining the specific recognition of hormone receptors. Vasotocin
is the non-mammalian vasopressin-like hormone or antidiuretic hormone regulating water
and salt metabolism.;
MeSH synonym : 3-isoleucyl vasopressin; (8-arginine)oxytocin; 3 isoleucyl vasopressin; vasopressin, 3-isoleucyl; arginine oxytocin; oxytocin, arginine; arginine vasotocin; vasotocin, arginine; argiprestocine; vasopressin, isoleucyl; isoleucyl vasopressin; vasopressin, non-mammalian; non-mammalian vasopressin; vasopressin, non mammalian; argiprestocin;
MeSH CAS label : Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly, cyclic 1-6 disulfide;
MeSH Related Number : 9034-50-8 (Vasotocin);
Registry Number MeSH : 9034-50-8;
Is substance : O;
UNII : W6S6URY8OF;
InChIKey : OXDZADMCOWPSOC-BQGUCLBMSA-N;
Origin ID : D014668;
UMLS CUI : C0042418;
Allowable qualifiers
Currated CISMeF NLP mapping
Indexing information
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
Semantic type(s)
UMLS correspondences (same concept)
A nonapeptide that contains the ring of OXYTOCIN and the side chain of ARG-VASOPRESSIN
with the latter determining the specific recognition of hormone receptors. Vasotocin
is the non-mammalian vasopressin-like hormone or antidiuretic hormone regulating water
and salt metabolism.
https://www.has-sante.fr/portail/jcms/c_2967172/fr/atosiban-accord
2019
false
false
false
France
atosiban
treatment outcome
insurance, health, reimbursement
threatened premature labor
obstetric labor, premature
adult
pregnancy
evaluation of the transparency committee
atosiban
vasotocin
vasotocin
---
http://www.has-sante.fr/portail/jcms/c_2743215/fr/atosiban-accord
2017
false
false
false
France
French
evaluation of the transparency committee
atosiban
Atosiban 7.5mg/mL infusion concentrate 5mL vial (product)
drugs, generic
atosiban
vasotocin
---
https://www.has-sante.fr/portail/jcms/c_2803492/fr/atosiban-ever-pharma
2017
false
false
false
false
France
French
evaluation of the transparency committee
atosiban
vasotocin
---
https://www.has-sante.fr/portail/jcms/c_2788641/fr/atosiban-stragen
2017
false
false
false
France
French
evaluation of the transparency committee
atosiban
vasotocin
---
http://www.has-sante.fr/portail/jcms/c_2756535/fr/atosiban-ever-pharma
2017
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
Product containing atosiban (medicinal product)
Atosiban 7.5mg/mL injection solution 0.9mL vial (product)
Atosiban 7.5mg/mL infusion concentrate 5mL vial (product)
atosiban
vasotocin
---
http://www.has-sante.fr/portail/jcms/c_2590007/fr/atosiban-panpharma
2016
false
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
atosiban
vasotocin
---
http://www.cochrane.org/fr/CD004452
2014
false
false
false
United Kingdom
France
barusiban
atosiban
tocolytic agents
barusiban
atosiban
tocolytic agents
treatment outcome
pregnancy
meta-analysis
french abstract
obstetric labor, premature
receptors, oxytocin
oligopeptides
vasotocin
vasotocin
oligopeptides
vasotocin
---
https://www.ema.europa.eu/medicines/human/EPAR/Tractocile
2012
United Kingdom
English
French
syndication feed
tocolytic agents
obstetric labor, premature
treatment outcome
drug evaluation
vasotocin
atosiban
drug evaluation
package leaflet
summary of product characteristics
atosiban
atosiban
drug approval
europe
clinical trials, phase iii as topic
breast feeding
drug evaluation, preclinical
tocolytic agents
hormone antagonists
hormone antagonists
receptors, oxytocin
infusions, intravenous
injections, intravenous
---